Results 231 to 240 of about 2,027,318 (403)

Flavonoids and the gastrointestinal tract: Local and systemic effects.

open access: yesMolecular Aspects of Medicine, 2018
P. Oteiza   +3 more
semanticscholar   +1 more source

APOL2 Stabilizes Ku80 to Confer NHEJ‐Mediated Radioresistance in Gastric Cancer

open access: yesAdvanced Science, EarlyView.
Radiotherapy resistance in gastric cancer (GC) is often mediated by enhanced DNA repair. APOL2 is found to promote NHEJ by stabilizing Ku80, conferring radioresistance. High APOL2 correlates with poor prognosis. Formononetin disrupts APOL2‐Ku80, restoring radiosensitivity, suggesting a novel therapeutic strategy.
Dan Zu   +23 more
wiley   +1 more source

Editorial: Biological rhythms in the brain and gastrointestinal tract. [PDF]

open access: yesFront Physiol
Jin J   +4 more
europepmc   +1 more source

Development of a 3D Human Colon Model Along with Bioelectronics for the Induction and Monitoring of Diseases

open access: yesAdvanced Science, EarlyView.
We present a functional three‐dimensional in‐vivo‐mimicking human colon (3D‐IVM‐HC) model engineered via Freeform Reversible Embedding of Suspended Hydrogels bioprinting with gelatin methacrylate (GelMA)/alginate hydrogels. This 3D non‐animal model replicates crypt‐like architectures, epithelial polarization, and stromal–tumor interactions, showing ...
Jorge Alfonso Tavares‐Negrete   +7 more
wiley   +1 more source

An ingestible device for automated sampling and location tracing in gastrointestinal tract. [PDF]

open access: yesPLoS One
Li T   +19 more
europepmc   +1 more source

Primary Lymphoma of the Gastrointestinal Tract

open access: green, 1969
Walter J. Loehr   +4 more
openalex   +2 more sources

Lenvatinib Plus Paclitaxel as Second‐Line Therapy for Advanced Gastric Cancer Patients: A Dose Escalation Exploratory Study

open access: yesAdvanced Science, EarlyView.
This study determines the maximum tolerated dose of lenvatinib in combination with paclitaxel as second‐line therapy for advanced gastric cancer patients. A dynamic network biomarker panel associated with patient prognosis and response to treatment is established.
Chenfei Zhou   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy